Trials / Completed
CompletedNCT00411437
Effects Of Detrol LA On Memory And Cognition In Elderly Population
A Randomized, Double-Blind, Placebo-Controlled, Three Arm Study To Evaluate The Effects Of Tolterodine ER 4 mg Vs. Placebo Vs. Oxybutynin ER On Memory And Other Cognitive Abilities In Elderly Subjects
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 220 (planned)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 65 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The primary purpose of the trial is to show that tolterodine ER has no effect on memory and other cognitive abilities in an elderly population
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tolterodine ER | |
| DRUG | Oxybutynin ER |
Timeline
- Start date
- 2006-12-01
- Primary completion
- 2007-06-01
- Completion
- 2007-06-01
- First posted
- 2006-12-14
- Last updated
- 2021-01-27
Locations
9 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00411437. Inclusion in this directory is not an endorsement.